EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Control of articular degeneration by extracellular vesicles from stem/stromal cells as a potential strategy for the treatment of osteoarthritis

María José Alcaraz

Biochemical Pharmacology · 2024

DOI: 10.1016/j.bcp.2024.116226 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochemical Pharmacology, 2024. Verfasst von María José Alcaraz. Beteiligte Einrichtung: Department of Pharmacology, University of Valencia, Av. Vicent A. Estellés s/n, 46100 Burjasot, Valencia, Spain. Electronic address: maria.j.alcaraz@…. Hauptthemen laut MEDLINE: Extracellular Vesicles, Osteoarthritis, Mesenchymal Stem Cells. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 204 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Federación Española de Enfermedades Raras, Ministerio de Ciencia e Innovación, España Ministerio de Ciencia Innovación y Universidades.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is a degenerative joint condition that contributes to years lived with disability. Current therapeutic approaches are limited as there are no disease-modifying interventions able to delay or inhibit the progression of disease. In recent years there has been an increasing interest in the immunomodulatory and regenerative properties of mesenchymal stem/stromal cells (MSCs) to develop new OA therapies. Extracellular vesicles (EVs) mediate many of the biological effects of these cells and may represent an alternative avoiding the limitations of cell-based therapy. There is also a growing interest in EV modifications to enhance their efficacy and applications. Recent preclinical studies have provided strong evidence supporting the potential of MSC EVs for the development of OA treatments. Thus, MSC EVs may regulate chondrocyte functions to avoid cartilage destruction, inhibit abnormal subchondral bone metabolism and synovial tissue alterations, and control pain behavior. EV actions may be mediated by the transfer of their cargo to target cells, with an important role for proteins and non-coding RNAs modulating signaling pathways relevant for OA progression. Nevertheless, additional investigations are needed concerning EV optimization, and standardization of preparation procedures. More research is also required for a better knowledge of possible effects on different OA phenotypes, pharmacokinetics, mechanism of action, long-term effects and safety profile. Furthermore, MSC EVs have a high potential as vehicles for drug delivery or as adjuvant therapy to potentiate or complement the effects of other approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesOsteoarthritisMesenchymal Stem CellsHumansAnimalsCartilage, ArticularMesenchymal Stem Cell Transplantation

Stichwörter der Autor:innen

CartilageExtracellular vesiclesInflammationMesenchymal stem/stromal cellsOsteoarthritismiRNAs

Autor:innen und Institutionen

  • Department of Pharmacology, University of Valencia, Av. Vicent A. Estellés s/n, 46100 Burjasot, Valencia, Spain. Electronic address: maria.j.alcaraz@uv.es.

Förderung

  • Federación Española de Enfermedades Raras
  • Ministerio de Ciencia e Innovación
  • España Ministerio de Ciencia Innovación y Universidades

Zitieren

APA

José Alcaraz, M. (2024). Control of articular degeneration by extracellular vesicles from stem/stromal cells as a potential strategy for the treatment of osteoarthritis. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2024.116226

Vancouver

José Alcaraz M. Control of articular degeneration by extracellular vesicles from stem/stromal cells as a potential strategy for the treatment of osteoarthritis. Biochemical Pharmacology. 2024. doi:10.1016/j.bcp.2024.116226

BibTeX
@article{JosAlcaraz2024,
  author = {José Alcaraz, María},
  title = {Control of articular degeneration by extracellular vesicles from stem/stromal cells as a potential strategy for the treatment of osteoarthritis},
  journal = {Biochemical Pharmacology},
  year = {2024},
  doi = {10.1016/j.bcp.2024.116226}
}
Kostenlos starten →